Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00157014 · ClinicalTrials.gov registry record · Phase 3
Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens
A Phase 3 study, sponsored by Astellas Pharma.
- Completed
- Registry status
- Phase 3
- Development phase
- 111
- Enrollment target
NCT00157014 is a Phase 3 study that has completed, run by Astellas Pharma. The registered enrollment target is 111 participants.
The verdict
NCT00157014, a Phase 3 study, has completed, sponsored by Astellas Pharma.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 111 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and efficacy of tacrolimus in de novo heart transplantation.
Interventions
- DRUG Prednisone
- DRUG Methylprednisolone
- DRUG Tacrolimus
- DRUG Cyclosporine
- DRUG Mycophenolate mofetil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2004-05-10 |
| Est. Completion | 2008-07-18 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00157014
The ClinicalTrials.gov registry entry for NCT00157014 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Astellas Pharma, which has 165 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Prednisone is the first listed.
NCT00157014 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00157014 about?
NCT00157014 is a clinical study titled "Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens". The purpose of this study is to assess the safety and efficacy of tacrolimus in de novo heart transplantation.
What is the current status of trial NCT00157014?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 111 participants. The study started on 2004-05-10. Estimated completion is 2008-07-18.
What interventions are being tested in trial NCT00157014?
The interventions under investigation include: Prednisone (DRUG), Methylprednisolone (DRUG), Tacrolimus (DRUG), Cyclosporine (DRUG), Mycophenolate mofetil (DRUG).
Who is sponsoring clinical trial NCT00157014?
This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.